Brevan Howard Capital Management’s Allogene Therapeutics ALLO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$152K	Sell	62,406 -8,023	-11%	-$16.1K	﹤0.01%	1964
2025 Q4	$96.5K	Buy	+70,429	New	+$92.9K	﹤0.01%	1676
2025 Q3	–	Sell	-81,843	Closed	-$92.5K	–	1917
2025 Q2	$92.5K	Sell	81,843 -163,774	-67%	-$218K	﹤0.01%	1788
2025 Q1	$359K	Buy	245,617 +158,044	+180%	+$298K	﹤0.01%	810
2024 Q4	$187K	Buy	87,573 +24,515	+39%	+$60.5K	﹤0.01%	920
2024 Q3	$177K	Buy	63,058 +3,353	+6%	+$8.94K	﹤0.01%	1014
2024 Q2	$139K	Buy	59,705 +27,519	+85%	+$81.2K	﹤0.01%	941
2024 Q1	$144K	Sell	32,186 -65,934	-67%	-$275K	﹤0.01%	853
2023 Q4	$315K	Buy	98,120 +79,743	+434%	+$226K	﹤0.01%	696
2023 Q3	$58.3K	Buy	+18,377	New	+$80.5K	﹤0.01%	360